Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems

Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems

Randi J Hagerman1,2, Deborah A Hall3, Sarah Coffey1,2, Maureen Leehey3, James Bourgeois4, John Gould5, Lin Zhang6, Andreea Seritan4, Elizabeth Berry-Kravis7–9, John Olichney6, Joshua W Miller10, Amy L Fong11, Randall Carpenter12, Cathy Bodine13, Louise W Gane1,2, Edgar Rainin1, Hillary Hag...

Full description

Bibliographic Details
Main Authors:	Randi J Hagerman, Deborah A Hall, Sarah Coffey, Maureen Leehey, James Bourgeois, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-06-01
Series:	Clinical Interventions in Aging
Online Access:	https://www.dovepress.com/treatment-of-fragile-x-associated-tremor-ataxia-syndrome-fxtas-and-rel-peer-reviewed-article-CIA

Similar Items

Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications
by: Ana Maria Cabal-Herrera, et al.
Published: (2020-06-01)

Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series
by: Maria Jimena Salcedo-Arellano, et al.
Published: (2020-05-01)

Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS).
by: Deborah A Hall, et al.
Published: (2020-01-01)

Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
by: Maria Jimena Salcedo-Arellano, et al.
Published: (2023-08-01)

The fragile x-associated tremor and ataxia syndrome (FXTAS) A síndrome de tremor e ataxia associada ao X frágil (FXTAS)
by: Leonardo Pires Capelli, et al.
Published: (2010-10-01)

New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype
by: Avram eFraint, et al.
Published: (2014-10-01)

A Chinese case of fragile X-associated tremor/ataxia syndrome (FXTAS) with orthostatic tremor:case report and literature review on tremor in FXTAS
by: Cuiping Zhao, et al.
Published: (2020-04-01)

Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): A Gender Perspective
by: Daniele Orsucci, et al.
Published: (2022-02-01)

Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS)
by: Ellery Santos, et al.
Published: (2023-12-01)

Fragile X-Associated Tremor/Ataxia Syndrome: Unmet Needs and a Path for the Future
by: Deborah A. Hall, et al.
Published: (2018-06-01)

FMR1 locus isoforms: potential biomarker candidates in fragile X-associated tremor/ataxia syndrome (FXTAS)
by: Marwa Zafarullah, et al.
Published: (2020-07-01)

Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approach
by: Michelle H. S. Tosin, et al.
Published: (2022-09-01)

Composition of the Intranuclear Inclusions of Fragile X-associated Tremor/Ataxia Syndrome
by: Lisa Ma, et al.
Published: (2019-09-01)

Making a Difference—Positive Effect of Unilateral VIM Gamma Knife Thalamotomy in the Therapy of Tremor in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
by: Piotr Alster, et al.
Published: (2018-06-01)

Corrigendum: Human Cerebral Cortex Proteome of Fragile X-Associated Tremor/Ataxia Syndrome
by: Katharine Nichole Holm, et al.
Published: (2021-05-01)

Sulforaphane improves mitochondrial metabolism in fibroblasts from patients with fragile X-associated tremor and ataxia syndrome
by: Eleonora Napoli, et al.
Published: (2021-09-01)

Increased Pain Symptomatology Among Females vs. Males With Fragile X-Associated Tremor/Ataxia Syndrome
by: Devon Johnson, et al.
Published: (2022-01-01)

Tremorography in fragile X-associated tremor/ataxia syndrome, Parkinson's disease and essential tremor
by: Erin E. Robertson, et al.
Published: (2020-01-01)

Fragile x-associated tremor/ataxia syndrome
by: A S Michel, et al.
Published: (2012-01-01)

Altered Redox Mitochondrial Biology in the Neurodegenerative Disorder Fragile X-Tremor/Ataxia Syndrome: Use of Antioxidants in Precision Medicine
by: Gyu Song, et al.
Published: (2016-06-01)

Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome
by: Jessica Famula, et al.
Published: (2022-03-01)

Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS
by: Marwa Zafarullah, et al.
Published: (2023-08-01)

Dementia in Fragile X-associated Tremor/Ataxia Syndrome
by: Ricardo Nitrini, et al.

Case Report: Coexistence of Alzheimer-Type Neuropathology in Fragile X-Associated Tremor Ataxia Syndrome
by: Maria Jimena Salcedo-Arellano, et al.
Published: (2021-09-01)

Late-onset Tremor and Ataxia Syndrome: Fragile X-Associated Tremor/Ataxia Syndrome and Neuroimaging Findings
by: Levent Öcek, et al.
Published: (2017-03-01)

Artificial neural network applied to fragile X-associated tremor/ataxia syndrome stage diagnosis based on peripheral mitochondrial bioenergetics and brain imaging outcomes
by: Cecilia Giulivi, et al.
Published: (2022-12-01)

A Postmortem MRI Study of Cerebrovascular Disease and Iron Content at End-Stage of Fragile X-Associated Tremor/Ataxia Syndrome
by: Jun Yi Wang, et al.
Published: (2023-07-01)

Neurodegeneration of White and Gray Matter in the Hippocampus with FXTAS
by: Maryam Kargar, et al.
Published: (2023-12-01)

Fragile X-Associated Tremor/Ataxia Syndrome: An Illustrative Case
by: Chaewon Lee, et al.
Published: (2019-09-01)

Fragile X-Associated Tremor Ataxia Syndrome: The Expanding Clinical Picture, Pathophysiology, Epidemiology, and Update on Treatment
by: Deborah A. Hall, et al.
Published: (2012-05-01)

95355 Potential Drug Therapy for Fragile X Tremor/Ataxia Syndrome
by: Collis Brown, et al.
Published: (2021-03-01)

400 Potential Drug Therapy for Fragile X Tremor/Ataxia Syndrome
by: Collis Brown, et al.
Published: (2022-04-01)

Digital gait markers to potentially distinguish fragile X-associated tremor/ataxia syndrome, Parkinson’s disease, and essential tremor
by: Erin E. Robertson-Dick, et al.
Published: (2023-12-01)

Neuropathology of RAN translation proteins in fragile X-associated tremor/ataxia syndrome
by: Amy Krans, et al.
Published: (2019-10-01)

Current Gaps in Understanding the Molecular Basis of FXTAS
by: Paul J. Hagerman
Published: (2012-05-01)

Cardiovascular Problems in the Fragile X Premutation
by: Nattaporn Tassanakijpanich, et al.
Published: (2020-10-01)

Fragile X-Associated Tremor/Ataxia Syndrome: From Molecular Pathogenesis to Development of Therapeutics
by: Ha Eun Kong, et al.
Published: (2017-05-01)

Non-canonical DNA/RNA structures associated with the pathogenesis of Fragile X-associated tremor/ataxia syndrome and Fragile X syndrome
by: Aadil Yousuf, et al.
Published: (2022-08-01)

In silico, in vitro, and in vivo Approaches to Identify Molecular Players in Fragile X Tremor and Ataxia Syndrome
by: Saif N. Haify, et al.
Published: (2020-03-01)

Prevalence of fragile X‐associated tremor/ataxia syndrome: A survey of essential tremor patients with cerebellar signs or extrapyramidal signs
by: Ji‐Hyung Park, et al.
Published: (2019-07-01)